RT @utswortho: It is #Sarcoma Awareness Month, and we are bringing awareness to this rare cancer. Thanks to the #UTSWOrtho oncology team….

RT @aguilera_md: Our article is out in yesterday’s issue! Grateful to all the patients & coauthors who made this possible. Huge thanks to P….

Happy 4th of July from Tia, our beloved facility dog, and all of us at Simmons Cancer Center!

@aguilera_md @CCR_AACR @UTSW_RadOnc.

In a study led by @aguilera_md & published in @CCR_AACR, #UTSW researchers found that adding stereotactic ablative radiotherapy (SAbR), a form of targeted radiation, before pancreatic cancer surgery reduces tumor regrowth & may improve clinical outcomes.

After nearly 20 years of dedicated research and clinical trials, Elizabeth Maher, M.D., Ph.D., and fellow #UTSW researchers developed vorasidenib, a groundbreaking FDA-approved medication that slows the growth of low-grade gliomas.

.@hmcarthur joins experts in an @OncLive discussion on #ASCO25 updates in HER2-positive metastatic breast cancer, covering first-line treatments, sequencing, and the role of CDK4/6 inhibitors for personalized care.

RT @TiansterZhang: Last week @andyzwang & I published 1st of our translational research in #MolecularCancer @BioMedCentral, developing a mu….

As a panelist in @CancerNetwrk's latest discussion, @hmcarthur, Clinical Director of our Breast Cancer Program, shares expert insights on evolving personalized approaches for treating HER2-positive breast cancer.

@JaviGBermudez @dylancalhoon.

Researchers at @CRI_UTSW discovered how tumors use glycosaminoglycans to take up antioxidant-rich lipoproteins. This pathway helps cancer cells survive stress and resist cell death, pointing to a potential new target for cancer treatment.

RT @TiansterZhang: Proud of our @utswcancer clinical research teams displaying our cancer center’s ongoing work in clinical trials @AACI_Ca….

UT Southwestern ranks among the top global sites in a groundbreaking bladder cancer trial, co-authored by @WaddahArafat and published in @Annals_Oncology, that helped establish a new standard of care for metastatic urothelial carcinoma.

Please join us in welcoming Daniel Addison, M.D., to our cardio-oncology team!. Dr. Addison also serves as the Director of Translational Research in the Cardiology Division & Associate Director for Survivorship & Outcomes Research. @md_addison. Learn more:

RT @MatthewSunMD: We just published this study evaluating an optimal cut-off for MIB-1 index in meningiomas:.@UTSWNeurosurg @utswcancer .ht….

@Peddada2Nagesh.

In a study published by @PNASNews, #UTSW researchers used cryo-electron microscopy to identify the structure of midnolin, a vital protein for the survival of malignant cells in some blood cancers. These findings could help guide the design of new drugs.

.@bsabari and fellow #UTSW researchers uncovered how gene fusions form biomolecular condensates that drive aggressive kidney cancers. Published in @CellCellPress, the findings suggest new treatment options and may hold promise for other types of cancer.

Congratulations to #UTSW scientist Fangyu Liu, Ph.D, on receiving the 2025 Damon Runyon-Dale F. Frey Award for Breakthrough Scientists for her research to discover new drug candidates to treat pancreatic, colorectal, breast, and prostate cancers.

RT @TiansterZhang: Leaving Chicago & #ASCO25 with full heart. Reminded of our common purpose to #curecancer and make a difference for our p….